# LRMDA

## Overview
The LRMDA gene, also known as c10orf11, encodes the leucine-rich melanocyte differentiation associated protein, which is integral to the development and function of melanocytes, the cells responsible for melanin production. This protein is characterized by the presence of leucine-rich repeats (LRRs), which are motifs known to facilitate protein-protein interactions and are involved in various cellular processes such as cell adhesion and signaling. LRMDA is crucial for the maturation of melanosomes, the organelles where melanin synthesis occurs, and influences key steps in the melanin synthesis pathway. Mutations in the LRMDA gene are linked to oculocutaneous albinism type 7 (OCA7), a condition marked by visual impairments and hypopigmentation, although skin and hair pigmentation may remain unaffected (Aamir2021Clinical; Kruijt2024Clinical; Fernández2021Genetics).

## Structure


## Function
The LRMDA gene, previously known as c10orf11, encodes a protein that plays a crucial role in the differentiation and function of melanocytes, the cells responsible for producing melanin, the pigment that gives color to the skin, hair, and eyes (Kruijt2024Clinical; Fernández2021Genetics). The LRMDA protein contains three leucine-rich repeats (LRRs) and one LRR C-terminal domain, which are involved in various cellular functions, including cell adhesion, signaling, and neuronal development (Kruijt2024Clinical).

In healthy human cells, LRMDA is localized on the limiting membrane of melanosomes, organelles involved in pigment synthesis and storage. It is essential for the maturation of melanosomes, which undergo several stages of development. During these stages, LRMDA influences the processing of premelanosomes protein (PMEL) and the activity of dopachrome tautomerase (DCT), an enzyme in the melanin synthesis pathway (Kruijt2024Clinical). Although mutations in LRMDA do not result in a complete lack of pigmentation, they lead to reduced pigmentation and a decrease in melanocyte numbers, highlighting its importance in pigmentation processes (Kruijt2024Clinical; Fernández2021Genetics).

## Clinical Significance
Mutations in the LRMDA gene are associated with oculocutaneous albinism type 7 (OCA7), a rare form of non-syndromic albinism. This condition is characterized by severely reduced visual acuity, nystagmus, hypopigmentation of the fundus, severe foveal hypoplasia, and chiasmal misrouting, while skin and hair pigmentation remain normal (Kruijt2024Clinical). OCA7 is linked to nonsense and frameshift variants in the LRMDA gene, with cases reported primarily from the Faroe Islands, Lithuania, and the Arabian Peninsula (Aamir2021Clinical). The LRMDA gene plays a role in melanocyte differentiation, and its mutations disrupt this pathway, leading to the hypopigmentation observed in OCA7 (Fernández2021Genetics).

The LRMDA gene encodes a protein with leucine-rich repeats involved in melanocyte development and differentiation. Knockdown studies in zebrafish have shown reduced pigmentation and melanocyte numbers, implicating LRMDA in melanin synthesis. Despite its role, mutations in LRMDA do not lead to complete depigmentation, suggesting partial functionality in melanin production (Kruijt2024Clinical). The protein localizes to melanosomes, which are involved in melanin synthesis and deposition. Understanding LRMDA's role may elucidate factors responsible for foveal hypoplasia and misrouting (Kruijt2024Clinical).


## References


[1. (Aamir2021Clinical) Abdullah Aamir, Helen J. Kuht, Karen Grønskov, Brian P. Brooks, and Mervyn G. Thomas. Clinical utility gene card for oculocutaneous (oca) and ocular albinism (oa)—an update. European Journal of Human Genetics, 29(10):1577–1583, January 2021. URL: http://dx.doi.org/10.1038/s41431-021-00809-w, doi:10.1038/s41431-021-00809-w. This article has 4 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41431-021-00809-w)

[2. (Kruijt2024Clinical) C. C. Kruijt, G. C. de Wit, H. M. van Minderhout, N. E. Schalij-Delfos, and M. M. van Genderen. Clinical and mutational characteristics of oculocutaneous albinism type 7. Scientific Reports, March 2024. URL: http://dx.doi.org/10.1038/s41598-024-57969-0, doi:10.1038/s41598-024-57969-0. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41598-024-57969-0)

[3. (Fernández2021Genetics) Almudena Fernández, Masahiro Hayashi, Gema Garrido, Andrea Montero, Ana Guardia, Tamio Suzuki, and Lluis Montoliu. Genetics of non‐syndromic and syndromic oculocutaneous albinism in human and mouse. Pigment Cell &amp; Melanoma Research, 34(4):786–799, May 2021. URL: http://dx.doi.org/10.1111/pcmr.12982, doi:10.1111/pcmr.12982. This article has 35 citations.](https://doi.org/10.1111/pcmr.12982)